Stocks & Investing
Tue, October 1, 2024
[ 12:00 AM ] - WOPRAI
Thu, August 22, 2024
[ 12:00 AM ] - WOPRAI
Wed, August 7, 2024
[ 12:00 AM ] - WOPRAI
Fri, August 2, 2024
[ 12:00 AM ] - WOPRAI
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 30, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 22, 2024
[ 12:00 AM ] - WOPRAI
Wed, April 3, 2024
[ 12:00 AM ] - WOPRAI
Mon, March 18, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
Thu, February 15, 2024
[ 12:00 AM ] - WOPRAI
Wed, February 14, 2024
[ 12:00 AM ] - WOPRAI
Mon, December 11, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, November 1, 2023
[ 12:00 AM ] - WOPRAI
Thu, October 26, 2023
[ 12:00 AM ] - WOPRAI
Mon, October 2, 2023
[ 12:00 AM ] - WOPRAI
Wed, September 6, 2023
[ 12:00 AM ] - WOPRAI
Fri, August 4, 2023
[ 12:00 AM ] - WOPRAI
Tue, July 11, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 24, 2023
[ 12:00 AM ] - WOPRAI
Wed, May 10, 2023
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
Fri, May 5, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 27, 2023
[ 12:00 AM ] - WOPRAI
Fri, March 3, 2023
[ 12:00 AM ] - WOPRAI
Thu, February 16, 2023 Patrick Donnelly Upgraded (BIO) to Strong Buy and Increased Target to $400 on, Oct 1st, 2024
Patrick Donnelly of Citigroup, Upgraded "Bio-Rad Laboratories, Inc." (BIO) to Strong Buy and Increased Target from $350 to $400 on, Oct 1st, 2024.
Patrick has made no other calls on BIO in the last 4 months.
There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Brandon Couillard of "Wells Fargo" Initiated at Hold and Held Target at $340 on, Tuesday, August 27th, 2024
This is the rating of the analyst that currently disagrees with Patrick
- Conor McNamara of "RBC Capital" Reiterated at Buy and Held Target at $401 on, Friday, August 16th, 2024
